Close Menu
Skip to main content
GenomeWeb
360Dx
Precision Oncology News
Precision Oncology News
*
*
Show password
Forgot your password?
Subscribe
Contains all of these words:
You may find more results for this query on our sister sites:
GenomeWeb
and
360Dx
.
Business & Policy
Business News
Regulatory News
Reimbursement
Biomarkers
BRCA
EGFR
HER2
KRAS
BRAF
ROS1
ALK
PD-L1
Cancer Specialties
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Brain Cancer
Melanoma
Pediatric Cancer
Oncology Trends
Next-Generation Sequencing
Minimal Residual Disease
Microsatellite Instability Testing
Immunotherapy
Liquid Biopsy
Resources
Webinars
White Papers
Conferences & Events
Partner Content
Menu
Home
›
About Us
›
Our Staff
›
Miriam Munn
Miriam Munn
Premium Content Account Manager
Phone Number
+1-212-651-5612
Email
[email protected]
Breaking
News
MacroGenics' Margenza Improves PFS Over Herceptin in Phase III Breast Cancer Trial
Exelixis Initiates Phase I Study of Anti-CDK7 Agent in Solid Tumors
In Brief This Week: Myriad Genetics, Diaceutics, Agios, Precipio, Lantern Pharma, Guardant Health
Kuur Therapeutics Reports Initial Activity of CAR NK-Cell Therapy in Neuroblastoma
Henry Ford Health System Opens New Cancer Pavilion With Precision Medicine Focus
Predictive Oncology Announces $4.1M Direct Offering
